Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcicor K2
- Development stage
- Unknown
- Lead developer
- Emblazon Life Sciences
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Calcicor K2 is a combination nutritional supplement developed and marketed by Emblazon Life Sciences for the management of bone-related disorders such as osteoporosis and osteopenia. The formulation typically comprises calcium citrate malate, vitamin D3 (cholecalciferol), and vitamin K2-7 (menaquinone-7). Calcium citrate malate serves as a highly bioavailable source of calcium for bone mineralization. Vitamin D3 facilitates the absorption of calcium from the gastrointestinal tract by activating the vitamin D receptor. Vitamin K2-7 acts as a vital cofactor for the carboxylation of bone proteins like osteocalcin, ensuring that calcium is effectively integrated into the bone matrix rather than depositing in the arterial walls, thereby supporting both skeletal and cardiovascular health.
- Brand names
- Calcicor K2
02
Targets
GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)
Beyond the preview
Go deeper on Calcicor K2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calcicor K2.